Kindred Biosciences - Ownership and Business Overview

Life ScienceCompany

Kindred Biosciences Ownership

Who owns Kindred Biosciences?

Kindred Biosciences is owned by Elanco Animal Health. It was acquired on June 16, 2021.

Kindred Biosciences Business Overview

Where is Kindred Biosciences headquartered?

Kindred Biosciences is headquartered in Burlingame, California.

What is Kindred Biosciences’ revenue?

Kindred Biosciences disclosed revenue of 42M USD for 2020 and 4M USD for 2019.

What sector is Kindred Biosciences in?

Kindred Biosciences is a life science company.

When was Kindred Biosciences founded?

Kindred Biosciences was founded in 2012.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 392 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 346 by strategics.

Kindred Biosciences

Kindred Biosciences, Inc.

1555 Bayshore Highway, Suite 200,
Burlingame, California 94010
United States,
(650) 701-7901
www.kindredbio.com

Kindred Biosciences is a biopharmaceutical company developing biologics focused to develop therapeutics based on these validated targets for dogs and cats. Kindred Biosciences was founded in 2012 and is based in Burlingame, California.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.